Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Bone Marrow-Derived Stem Cells and Strategies for Treatment of Nervous System Disorders: Many Protocols, and Many Results.
Morning serum melatonin values in multiple sclerosis: A biochemical evaluation.
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer's Disease, and Multiple Sclerosis.
Multiple sclerosis: Repurposing dopaminergic drugs for MS - the evidence mounts.
The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Microsurgical Pontine Descending Tractotomy in Cases of Intractable Trigeminal Neuralgia.
Extracellular vesicles as modulators of cell-to-cell communication in the healthy and diseased brain.
MRI measures should be a primary outcome endpoint in phase III randomized controlled trials in multiple sclerosis: No.
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
CX3CR1 in multiple sclerosis.
Neuro-Ophthalmic Syndromes and Processing Speed in Multiple Sclerosis.
Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis.
Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
Thiopalmitoylation of Altered Peptide Ligands Enhances Their Protective Effects in an Animal Model of Multiple Sclerosis.
[Diet and multiple sclerosis].
Fingolimod (Gilenya) may improve the chances of conception in women with multiple sclerosis (MS) associated with secondary infertlity.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Longitudinally extensive transverse myelitis in neuromyelitis optica: a prospective study of 13 Caucasian patients and literature review.
Alternative Approaches: A Systematic Review of Non-Pharmacological Treatments for Non-Spastic and Non-Trigeminal Pain in Patients with Multiple Sclerosis.
Autoantibody profiling in multiple sclerosis using arrays of human protein fragments.
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
Double Inversion Recovery Sequence of the Cervical Spinal Cord in Multiple Sclerosis and Related Inflammatory Diseases.
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »